HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Neil L Berinstein Selected Research
Neil L Berinstein Research Topics
Disease
22
Neoplasms (Cancer)
10/2018 - 04/2002
6
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2018 - 11/2002
4
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
02/2004 - 02/2002
3
Colorectal Neoplasms (Colorectal Cancer)
10/2018 - 11/2007
3
Lymphoma (Lymphomas)
06/2014 - 02/2006
3
Prostatic Neoplasms (Prostate Cancer)
01/2014 - 02/2010
3
Melanoma (Melanoma, Malignant)
10/2010 - 04/2008
2
Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 06/2012
2
Squamous Cell Carcinoma of Head and Neck
01/2018 - 06/2012
2
Necrosis
01/2018 - 06/2012
2
Fibrosis (Cirrhosis)
01/2018 - 06/2012
2
Injection Site Reaction
01/2014 - 08/2012
2
Squamous Cell Neoplasms (Squamous Cell Cancer)
06/2012 - 06/2012
2
Carcinogenesis
10/2011 - 04/2002
2
Breast Neoplasms (Breast Cancer)
02/2010 - 08/2005
2
Tetanus
08/2008 - 02/2006
2
Disease Progression
08/2008 - 05/2003
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2006 - 11/2002
1
Thrombocytopenia (Thrombopenia)
04/2018
1
Neutropenia
04/2018
1
Rubella (German Measles)
04/2018
1
Ovarian Neoplasms (Ovarian Cancer)
08/2015
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2014
1
B-Cell Lymphoma (Lymphoma, B Cell)
06/2014
1
Leiomyosarcoma
04/2008
1
Neoplasm Metastasis (Metastasis)
04/2008
1
Communicable Diseases (Infectious Diseases)
11/2007
1
Papillary Carcinoma
08/2005
1
Noninfiltrating Intraductal Carcinoma (DCIS)
08/2005
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2003
1
Graft vs Host Disease (Graft-Versus-Host Disease)
11/2002
1
Residual Neoplasm
11/2002
Drug/Important Bio-Agent (IBA)
12
Vaccines
IBA
01/2016 - 04/2002
8
Antigens
IBA
01/2016 - 04/2008
7
Cancer Vaccines
IBA
01/2016 - 05/2003
7
Peptides (Polypeptides)
IBA
01/2016 - 02/2006
6
IRX 2
IBA
01/2018 - 10/2011
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2016 - 01/2014
4
Monoclonal Antibodies
IBA
09/2009 - 02/2004
3
Immunoglobulins (Immunoglobulin)
IBA
04/2018 - 04/2002
3
Cytokines
IBA
01/2018 - 09/2009
3
Rituximab (Mabthera)
FDA Link
06/2014 - 02/2002
2
Biomarkers (Surrogate Marker)
IBA
10/2018 - 11/2002
2
Biological Products
IBA
01/2018 - 06/2012
2
DNA (Deoxyribonucleic Acid)
IBA
01/2016 - 08/2005
2
Proteins (Proteins, Gene)
FDA Link
01/2016 - 08/2005
2
2-Methyl-4-chlorophenoxyacetic Acid (MCPA)
IBA
01/2016 - 01/2014
2
Prednisone (Sone)
FDA Link
Generic
06/2014 - 06/2014
2
Vincristine (Oncovin)
FDA Link
Generic
06/2014 - 06/2014
2
DPX-0907
IBA
01/2014 - 08/2012
2
HLA-A2 Antigen (HLA A2 Antigen)
IBA
01/2014 - 08/2012
2
Epitopes
IBA
10/2011 - 04/2002
1
Fibronectins (Fibronectin)
IBA
10/2018
1
Carcinoembryonic Antigen
IBA
10/2018
1
ibritumomab tiuxetan (Zevalin)
FDA Link
04/2018
1
Chemokines
IBA
01/2018
1
Chemokine Receptors
IBA
01/2018
1
Immunologic Factors (Immunomodulators)
IBA
01/2016
1
Survivin
IBA
08/2015
1
R-CHOP protocol
IBA
06/2014
1
Doxorubicin (Adriamycin)
FDA Link
Generic
06/2014
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2014
1
Protein Subunit Vaccines
IBA
01/2014
1
Emulsions
IBA
08/2012
1
Eosine Yellowish-(YS) (Eosin)
IBA
06/2012
1
Coloring Agents (Dyes)
IBA
06/2012
1
Hematoxylin (Haematoxylon)
IBA
06/2012
1
Neoplasm Antigens (Tumor Antigens)
IBA
10/2011
1
Estrogen Receptor alpha
IBA
02/2010
1
Androgens
IBA
02/2010
1
GATA Transcription Factors
IBA
02/2010
1
Antioxidants
IBA
02/2010
1
Progesterone Receptors (Progesterone Receptor)
IBA
02/2010
1
Fluorouracil (Carac)
FDA Link
Generic
08/2008
1
Tetanus Toxoid (Vaccine, Tetanus)
FDA Link
08/2008
1
Leucovorin (Folinic Acid)
FDA Link
08/2008
1
Irinotecan (Camptosar)
FDA Link
Generic
08/2008
1
Interleukin-2 (IL2)
IBA
04/2008
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
04/2008
1
Autoantigens
IBA
11/2007
1
gp100 Melanoma Antigen
IBA
02/2006
1
Viral Vaccines
IBA
02/2006
1
SYBR Green I
IBA
02/2006
Therapy/Procedure
13
Therapeutics
01/2018 - 02/2002
10
Immunotherapy
04/2018 - 02/2002
6
Drug Therapy (Chemotherapy)
06/2014 - 11/2002
4
Stem Cell Transplantation
02/2006 - 02/2002
1
Injections
01/2018
1
Neoadjuvant Therapy
06/2012
1
Combination Drug Therapy (Combination Chemotherapy)
08/2008